242 related articles for article (PubMed ID: 22073272)
1. Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
Kus V; Flachs P; Kuda O; Bardova K; Janovska P; Svobodova M; Jilkova ZM; Rossmeisl M; Wang-Sattler R; Yu Z; Illig T; Kopecky J
PLoS One; 2011; 6(11):e27126. PubMed ID: 22073272
[TBL] [Abstract][Full Text] [Related]
2. Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice.
Horakova O; Medrikova D; van Schothorst EM; Bunschoten A; Flachs P; Kus V; Kuda O; Bardova K; Janovska P; Hensler M; Rossmeisl M; Wang-Sattler R; Prehn C; Adamski J; Illig T; Keijer J; Kopecky J
PLoS One; 2012; 7(8):e43764. PubMed ID: 22952760
[TBL] [Abstract][Full Text] [Related]
3. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.
Kuda O; Jelenik T; Jilkova Z; Flachs P; Rossmeisl M; Hensler M; Kazdova L; Ogston N; Baranowski M; Gorski J; Janovska P; Kus V; Polak J; Mohamed-Ali V; Burcelin R; Cinti S; Bryhn M; Kopecky J
Diabetologia; 2009 May; 52(5):941-51. PubMed ID: 19277604
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids.
Flachs P; Rühl R; Hensler M; Janovska P; Zouhar P; Kus V; Macek Jilkova Z; Papp E; Kuda O; Svobodova M; Rossmeisl M; Tsenov G; Mohamed-Ali V; Kopecky J
Diabetologia; 2011 Oct; 54(10):2626-38. PubMed ID: 21779874
[TBL] [Abstract][Full Text] [Related]
5. Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue.
Bardova K; Funda J; Pohl R; Cajka T; Hensler M; Kuda O; Janovska P; Adamcova K; Irodenko I; Lenkova L; Zouhar P; Horakova O; Flachs P; Rossmeisl M; Colca J; Kopecky J
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291653
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice.
Jilkova ZM; Hensler M; Medrikova D; Janovska P; Horakova O; Rossmeisl M; Flachs P; Sell H; Eckel J; Kopecky J
Int J Obes (Lond); 2014 Feb; 38(2):216-23. PubMed ID: 23756677
[TBL] [Abstract][Full Text] [Related]
7. Corn oil versus lard: Metabolic effects of omega-3 fatty acids in mice fed obesogenic diets with different fatty acid composition.
Pavlisova J; Bardova K; Stankova B; Tvrzicka E; Kopecky J; Rossmeisl M
Biochimie; 2016 May; 124():150-162. PubMed ID: 26151346
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.
Villarroya J; Flachs P; Redondo-Angulo I; Giralt M; Medrikova D; Villarroya F; Kopecky J; Planavila A
Lipids; 2014 Nov; 49(11):1081-9. PubMed ID: 25204579
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.
Jelenik T; Rossmeisl M; Kuda O; Jilkova ZM; Medrikova D; Kus V; Hensler M; Janovska P; Miksik I; Baranowski M; Gorski J; Hébrard S; Jensen TE; Flachs P; Hawley S; Viollet B; Kopecky J
Diabetes; 2010 Nov; 59(11):2737-46. PubMed ID: 20693347
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice.
Hensler M; Bardova K; Jilkova ZM; Wahli W; Meztger D; Chambon P; Kopecky J; Flachs P
Lipids Health Dis; 2011 Aug; 10():128. PubMed ID: 21810216
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients.
Rossmeisl M; Pavlisova J; Janovska P; Kuda O; Bardova K; Hansikova J; Svobodova M; Oseeva M; Veleba J; Kopecky J; Zacek P; Fiserova E; Pelikanova T; Kopecky J
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):712-725. PubMed ID: 29626526
[TBL] [Abstract][Full Text] [Related]
12. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
13. Long-term dietary supplementation with saury oil attenuates metabolic abnormalities in mice fed a high-fat diet: combined beneficial effect of omega-3 fatty acids and long-chain monounsaturated fatty acids.
Yang ZH; Inoue S; Taniguchi Y; Miyahara H; Iwasaki Y; Takeo J; Sakaue H; Nakaya Y
Lipids Health Dis; 2015 Dec; 14():155. PubMed ID: 26627187
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of palmitoleic acid may contribute to beneficial effects of Krill oil on glucose homeostasis in dietary obese mice.
Rossmeisl M; Pavlisova J; Bardova K; Kalendova V; Buresova J; Kuda O; Kroupova P; Stankova B; Tvrzicka E; Fiserova E; Horakova O; Kopecky J
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158732. PubMed ID: 32371092
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.
Rossmeisl M; Jilkova ZM; Kuda O; Jelenik T; Medrikova D; Stankova B; Kristinsson B; Haraldsson GG; Svensen H; Stoknes I; Sjövall P; Magnusson Y; Balvers MG; Verhoeckx KC; Tvrzicka E; Bryhn M; Kopecky J
PLoS One; 2012; 7(6):e38834. PubMed ID: 22701720
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
17. Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants.
Djaouti L; Jourdan T; Demizieux L; Chevrot M; Gresti J; Vergès B; Degrace P
Diabetes Metab Res Rev; 2010 May; 26(4):297-305. PubMed ID: 20503262
[TBL] [Abstract][Full Text] [Related]
18. Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis.
Janovská P; Flachs P; Kazdová L; Kopecký J
Physiol Res; 2013; 62(2):153-61. PubMed ID: 23234412
[TBL] [Abstract][Full Text] [Related]
19. Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese mice.
Pavlisova J; Horakova O; Kalendova V; Buresova J; Bardova K; Holendova B; Plecita-Hlavata L; Vackova S; Windrichova J; Topolcan O; Kopecky J; Rossmeisl M
Food Funct; 2020 Nov; 11(11):9764-9775. PubMed ID: 33078809
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.
Deeg MA; Buse JB; Goldberg RB; Kendall DM; Zagar AJ; Jacober SJ; Khan MA; Perez AT; Tan MH;
Diabetes Care; 2007 Oct; 30(10):2458-64. PubMed ID: 17595355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
